Some Types of Prostate Cancer May Not be as Aggressive as Originally Thought
June 4th 2020Researchers at the UCLA Jonsson Comprehensive Cancer Center analyze gene-expression patterns in the most aggressive prostate cancer grade group—known as Gleason grade group 5—and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences.
Read More
New Treatment Extends Lives of People With Most Common Type of Liver Cancer
May 14th 2020For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.
Read More
Roswell Park to Assess Immunotherapy Combination in Cancer Patients With COVID-19
May 12th 2020A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.
Read More
Current and Emerging Treatments for Gastroenteropancreatic Neuroendocrine Tumors
May 4th 2020During an OncLive® scientific interchange, panelists discussed the current treatment landscape for patients with gastroenteropancreatic-neuroendocrine tumors and the need for improved novel therapies.
Read More
Florida Cancer Specialists Launches Telehealth Services in Response to Coronavirus (COVID-19)
April 8th 2020Florida Cancer Specialists & Research Institute recently launched telehealth services across all Florida Cancer Specialists & Research Institute sites statewide, allowing patients continued and convenient access to care, while mitigating the impact and spread of COVID-19.
Read More
Roswell Park's Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort
March 31st 2020A team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center has earned a five-year, $14.54 million award from the National Cancer Institute to expand a promising immunotherapy platform.
Read More
Experts Weigh In on Top Abstracts From Genitourinary Cancers Symposium
March 18th 2020How to best pair immune checkpoint inhibitors with other agents known to have efficacy in genitourinary cancers was a key avenue of inquiry of many of the studies presented at the 2020 Genitourinary Cancers Symposium.
Read More
Randall A. Oyer, MD, Becomes President of the Association of Community Cancer Centers
March 11th 2020Randall A. Oyer, MD, was named the Association of Community Cancer Centers (ACCC) President for 2020-2021 at the ACCC 46th Annual Meeting & Cancer Center Business Summit held March 4-6 in Washington, D.C.
Read More